PRELID3BP7

Across TCGA pan-cancer cohorts, PRELID3BP7 RNA is linked to patient survival in 13 of 34 cancer types, making it the most broadly survival-associated PRELID3BP7 data layer.

The strongest signal is observed in bladder urothelial carcinoma (BLCA), where higher PRELID3BP7 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated PRELID3BP7 expression acts as an unfavorable survival marker, although some lineages such as LUAD and OV show a favorable association.

BLCA, READ, and LUAD are the cancer types where PRELID3BP7 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BLCA	DFS	Tertile	II,III,IV	0.501	0.637	.005	72	view →
READ	OS	Tertile	IV	0.547	0.953	.001	57	view →
LUAD	DFS	Tertile	All	0.854	0.759	.004	54	view →
OV	OS	Median	II,III,IV	0.745	0.648	.005	52	view →
BRCA	DFS	Tertile	IV	0.175	0.730	.005	36	view →
DLBC	OS	Tertile	III,IV	0.172	0.907	<.001	36	view →
LGG	OS	Tertile	All	0.720	0.826	.011	27	view →
ACC	OS	Tertile	All	0.227	0.641	.023	15	view →
CHOL	DFS	Tertile	III,IV	1.000	0.182	.034	9	view →
CESC	OS	Tertile	All	0.923	0.845	.028	8	view →
LIHC	OS	Tertile	All	0.320	0.597	.014	6	view →
ESCA	DFS	Median	III,IV	0.446	0.250	.034	3	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 13 lineages.

PRELID3BP7–BLCA (DFS)

Open the BLCA breakdown →